Arcutis Biotherapeutics director Terrie Curran disposes of 1,072 common shares worth $27,927.31 - ARQT News | RalliesArcutis Biotherapeutics director Terrie Curran disposes of 1,072 common shares worth $27,927.31
A
ARQT• Director exercises options and sells shares
- Arcutis Biotherapeutics director Terrie Curran exercised stock options for 1,072 common shares at USD 7.51 on Aug. 20, 2026.
- Curran sold 1,072 common shares at a weighted average price of USD 26.04 on the same day.
- Directly held common shares fell to 23,526 following the transactions.
- Directly held stock options decreased to 11,148.
MCRP
•
